NCT01391832

Brief Summary

The objective will be to determine if adding repetitive transcranial magnetic stimulation prior to Cognitive Processing Therapy significantly enhances recovery from hyperarousal symptoms in individuals with combat related post traumatic stress disorder and improves clinical outcome. The investigators have assembled a multimodal human performance laboratory including 64 channel EEG and repetitive transcranial magnetic stimulation system. These resources combined with the neuroimaging capabilities of the Advanced Imaging Research Center (AIRC) at UT Southwestern and skilled Cognitive Processing Therapy (CPT) practitioners will be used in this study. The study involves approximately 19 visits. Treatment is once a week for 12 weeks followed by a 1 month, 3 month and 6 month follow-up appointments.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
103

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jul 2011

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2011

Completed
4 days until next milestone

First Submitted

Initial submission to the registry

July 5, 2011

Completed
7 days until next milestone

First Posted

Study publicly available on registry

July 12, 2011

Completed
4.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2016

Completed
4.7 years until next milestone

Results Posted

Study results publicly available

October 1, 2020

Completed
Last Updated

January 22, 2024

Status Verified

January 1, 2024

Enrollment Period

4.6 years

First QC Date

July 5, 2011

Results QC Date

August 5, 2020

Last Update Submit

January 18, 2024

Conditions

Keywords

rTMSPTSDPost Traumatic Stress Disorderrepetitive transcranial magnetic stimulationcombat related PTSDOEFOIFVeteransoperation enduring freedomoperation iraqi freedomCPTcognitive processing therapy

Outcome Measures

Primary Outcomes (1)

  • Change From Baseline to Follow-up in Clinician Administered Post-Traumatic Stress Disorder Scale Total Severity Score

    The primary outcome measure of treatment efficacy for post-traumatic stress disorder (PTSD) will be change in the Clinician Administered Post-Traumatic Stress Disorder Scale (CAPS) Total Severity Score (i.e., summed across frequency and intensity ratings for the 17 PTSD assessment items) from baseline at 1-month post-treatment. CAPS Total Severity Score ranges from 0 to 136. Difference scores were calculated as the outcome score minus the baseline score, with negative scores indicating a reduction in symptom severity from baseline (i.e., a positive treatment outcome), and differences between treatment groups in change scores were evaluated using t-tests.

    Outcome measures will be measured as change from baseline at 1-, 3-, and 6-month follow-ups

Secondary Outcomes (1)

  • Changes in ERP/CAPS Cluster Scores Signals From Pre-Treatment to Post-Treatment

    Outcomes will be assessed at baseline and 6-month follow-up

Study Arms (2)

Sham rTMS

SHAM COMPARATOR

Sham Treatment Intervention: Device: Repetitive Transcranial Magnet Stimulation (sham treatment)

Device: Repetitive Transcranial Magnetic Stimulation (rTMS)Behavioral: Cognitive Processing Therapy

active rTMS

ACTIVE COMPARATOR

Active Repetitive Transcranial Magnet Stimulation treatment Intervention: Device: Active rTMS of dorsolateral pre-frontal cortex

Behavioral: Cognitive Processing TherapyDevice: Repetitive Transcranial Magnet Stimulation (rTMS)

Interventions

For the sham rTMS with CPT group, the rTMS coil will be placed over the right prefrontal scalp region with the MagStim Rapid Stimulator set to the sham mode so that all conditions are similar to the active delivery mode except that transcranial magnetic stimulation is not administered to the scalp and does not down modulate the right frontal lobe.

Also known as: rTMS, magnet stimulation
Sham rTMS

Cognitive Processing Therapy (CPT) is a 12 session evidenced based, trauma-focused treatment for PTSD. CPT is a cognitive therapy based on information processing theory and includes components which help the client to (a) access her or his memory of the event, (b) identify and experience her or his emotions until they have been extinguished, and (c) identify and challenge beliefs about the event itself and beliefs about self and the world which have been altered because of the combat related trauma.

Also known as: CPT, behavioral training, behavioral therapy
Sham rTMSactive rTMS

For the active rTMS with CPT group, the rTMS coil will be placed over the right prefrontal scalp region with the MagStim Rapid Stimulator set to the active mode. After motor threshold determination, the stimulator coil is positioned over the dorsolateral prefrontal cortex - DLPFC (Brodmann Area 9/46). The right frontal rTMS will safely, reversibly, and temporarily down modulate the right frontal lobe. The conducting coil is placed over the scalp while electrical current pulses pass through the coil. This alternating current turned on and off rapidly produces magnetic pulses (1.5-2.0 Tesla strength) that last for 100 - 300 microseconds. The time-varying magnetic pulses induce an electrical field that will result in current flow in neural tissue, thereby activating or deactivating cortex subjacent to the coil.

active rTMS

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Veterans of Operation Iraqi Freedom (OIF) or Operation Enduring Freedom (OEF)
  • years
  • Diagnosis or symptoms of Combat related PTSD/ PCL Score Indicative of diagnosis (prior diagnosis not required).
  • English speaking
  • This study is also looking for civilian and miltary control subjects for assessment phase participation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Texas at Dallas

Dallas, Texas, 75235, United States

Location

MeSH Terms

Conditions

Stress Disorders, Post-Traumatic

Interventions

Transcranial Magnetic Stimulation2-cyclohexylidenhydrazo-4-phenyl-thiazoleBehavior Therapy

Condition Hierarchy (Ancestors)

Stress Disorders, TraumaticTrauma and Stressor Related DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Magnetic Field TherapyTherapeuticsPsychotherapyBehavioral Disciplines and Activities

Results Point of Contact

Title
Dr. John Hart, Jr.
Organization
University of Texas at Dallas

Study Officials

  • John Hart Jr., M.D.

    The University of Texas at Dallas

    PRINCIPAL INVESTIGATOR
  • F. Andrew Kozel, M.D.

    University of Texas

    STUDY DIRECTOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

July 5, 2011

First Posted

July 12, 2011

Study Start

July 1, 2011

Primary Completion

February 1, 2016

Study Completion

February 1, 2016

Last Updated

January 22, 2024

Results First Posted

October 1, 2020

Record last verified: 2024-01

Locations